University To Pay $15 Million To Brain-Injured Girl

0 comments

Posted on 14th July 2013 by gjohnson in Uncategorized

, , , , ,

In one of he largest medical malpractice settlements in the state’s history, the University of Washington (UW) will pay $15 million to the family of a girl who suffered traumatic brain injury (TBI) after using a nasal decongestant recommended by the school’s physician at Seattle Children’s Hospital, according to the University Herald.

http://www.universityherald.com/articles/3868/20130713/washington-university-pay-15-million-medical-malpractice-settlement-left-girl.htm

It’s unclear if a judge ordered the award or if it was a settlement, since the $15 million is described both ways in the story. At one point the story said that a  judge in King County Superior Court had ordered the award in the case involving MacKenzie Bryant. Her family filed suit against the hospital and UW.

In another section of the story, the money was described as a settlement.

MacKenzie got a cold, and had blocked nasal passages about four years ago. Dr. Cory Noel, a university cardiology fellow, suggested she take Afrin, despite the fact that the child’s cardiologist, Dr. Yuk Law, had warned that she shouldn’t take the decongestant because of her heart condition, the University Herald reported.

MacKenzie had previously had a  heart transplant.

Law was correct in his warning. MacKenzie had a cardiac arrest not long after her mother gave her the Afrin. As a result of the cardiac arrest, the girl’s brain was deprived of oxygen and she suffered TBI. Now she must have round-the-clock nursing care. She can’t talk, has to get nourishment through a stomach tube, and can’t move.

According to the University Herald, UW apologized for the girl’s brain injury but defended its doctor.

“We believe that the use of Afrin, a commonly used over-the-counter cold remedy, did not lead to MacKenzie’s [cardiac arrest]: However, the judge on this case ruled in favor of the plaintiff and her family,” the university said in a statement.

 

 

 

No comments yet.

Leave a comment